港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

恒瑞医药

70.800

-0.300-0.42%

成交量：286.76万

成交额：2.05亿

市值：4,699.00亿

市盈率：64.70

高：72.600

开：70.900

低：70.700

收：71.100

52周最高：95.200

52周最低：52.500

股本：66.37亿

香港流通股本：2.58亿

量比：0.77

换手率：1.11%

股息：- -

股息率：- -

每股收益(LYR):1.094

净资产收益率：14.34%

总资产收益率：8.37%

市净率：7.22

市盈率(LYR):64.70

市销率: 13.86

数据加载中...

总览公司新闻资讯公告

花旗集团在恒瑞医药的H股多头头寸于11月3日降至4.67%，较5.30%有所减少

跨国药企中国两条腿走路：加速全球引进，与本土创新药一起出海

恒瑞医药11月07日主力净流出495.6万元散户资金买入

智通AH统计|11月7日

三季度财报印证马太效应，290家医药上市企业整体减收又减利，而恒瑞医药净利57.51亿领跑

医药行业研究报告

药界周刊（2025.11.1—11.7）

【中泰策略】全A盈利改善，结构主线明确——2025年A股三季报点评

修炼投资的水晶球

拟纳入优先审评，“中国版”替尔泊肽来了

CPHI制药在线

恒瑞创新药、补体B因子抑制剂HRS-5965拟纳入优先审评程序

Wellington Management Group LLP增持恒瑞医药(01276)85.56万股每股作价72.6411港元

八赴进博！GSK展台全新升级，变局中重构“再增长曲线”

MedTrend医趋势

上海浦东三大先导产业集聚度进一步提升

每日卖空追踪 | 恒瑞医药 11月06日卖空量成交47.44万股，卖空比例为14.8%

速递 | 外国人，是如何教外企跟中国BioPharma打交道的？

GLP1减重宝典

【火热】48款新药进院在即，独家品种优势十足

恒瑞医药三季度急刹车：费用增加拖累利润，40亿海外首付款去哪了？

1.85亿美元A轮融资！恒瑞NewCo公司Braveheart能否攻克心肌病？

华创消费观察 | 11月观点速递：大消费三季报掘金，把握拐点

华创证券研究

新版《医疗器械生产质量管理规范》将施行；卓正医疗递表港交所

商保创新药目录落地势必重构产业生态

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/01276/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"恒瑞医药","latestPrice":70.8,"timestamp":1763453299003,"preClose":71.1,"halted":0,"volume":2867625,"delay":0,"floatShares":258000000,"shares":6637000000,"eps":1.0943394757534,"marketStatus":"已收盘","change":-0.3,"latestTime":"11-18 16:08:19","open":70.9,"high":72.6,"low":70.7,"amount":205288749,"amplitude":0.026723,"askPrice":70.85,"askSize":4600,"bidPrice":70.8,"bidSize":12600,"shortable":3,"etf":0,"ttmEps":1.2696614144849006,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763515800000},"marketStatusCode":5,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":71.1,"openAndCloseTimeList":[[1763429400000,1763438400000],[1763442000000,1763452800000]],"volumeRatio":0.76824,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"恒瑞医药","latestPrice":61.78,"timestamp":1763449200000,"preClose":61.8,"halted":0,"volume":21910000,"delay":0,"premium":"+4.72"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"8.37%","roe":"14.34%","lyrEps":1.094339,"volumeRatio":0.76824,"shares":6637000000,"dividePrice":0,"high":72.6,"amplitude":0.026723,"preClose":71.1,"low":70.7,"week52Low":52.5,"pbRate":"7.22","psRate":"13.86","week52High":95.2,"institutionHeld":0,"latestPrice":70.8,"committee":0.465116,"eps":1.0943394757534,"divideRate":0,"volume":2867625,"delay":0,"ttmEps":1.2696614144849006,"open":70.9,"prevYearClose":44.05,"prevWeekClose":71.6,"prevMonthClose":75.2,"prevQuarterClose":88.8,"fiveDayClose":70.85,"twentyDayClose":79.25,"sixtyDayClose":77.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2025-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761615000000,"name":null,"time":"","dateTimestamp":1761580800000,"actualEps":null},{"date":"2025-08-21","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755739800000,"name":null,"time":"","dateTimestamp":1755705600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.5714,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1760716800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2025-11-17","current":55.792207,"percent":0.292683,"low":50.027905,"twenty":52.873142,"median":57.752122,"eighty":62.273725,"high":65.582363,"avg":57.75041,"sd":4.614457,"marketCap":448676436005.11},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-17","current":54.931735,"twenty":52.873142,"median":57.752122,"eighty":62.273725,"marketCap":448676436005.11}],"updateTime":1763453341580},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1197054802","title":"花旗集团在恒瑞医药的H股多头头寸于11月3日降至4.67%，较5.30%有所减少","url":"https://stock-news.laohu8.com/highlight/detail?id=1197054802","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197054802?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 17:18","pubTimestamp":1762507100,"startTime":"0","endTime":"0","summary":"花旗集团在恒瑞医药的H股多头头寸于11月3日降至4.67%，较之前的5.30%有所减少。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","LU1255011170.USD","BK0028","LU2328871848.SGD","BK0188","LU0359201885.HKD","LU0359202008.SGD","LU1023057109.AUD","LU1146622755.USD","LU2148510915.USD","LU2097828805.USD","LU0405327148.USD","LU1969619763.USD","LU2495084118.USD","LU1580142542.USD","LU2488822045.USD","LU2289578879.USD","LU1997245094.SGD","LU2580892862.HKD","BK0183","LU1655091616.SGD","LU2580892789.USD","BK0196","LU0359201612.USD","600276","LU2097828474.EUR","LU1997244956.HKD","LU1064131003.USD","LU1997245177.USD","LU2097828631.EUR","BK0060","BK1191","LU0405327494.USD","LU2097828714.EUR","BK0012","LU1820825898.SGD","LU1328615791.USD","LU2097828557.USD","LU1781817850.SGD","BK0239","LU2543165471.USD","01276"],"gpt_icon":0},{"id":"2581880053","title":"跨国药企中国两条腿走路：加速全球引进，与本土创新药一起出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2581880053","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581880053?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 17:03","pubTimestamp":1762506236,"startTime":"0","endTime":"0","summary":"随着中国在生物制药领域的快速发展，多家跨国药企负责人表示，他们的中国策略进行了相应调整：既要加强中国市场投入，加速把全球创新产品引入中国市场，也要通过BD交易等方式，与中国创新共同拓展全球市场。GSK中国也希望成为GSK全球的创新中心。“我们会把中国纳入第一阵营，让中国参与全球临床试验的早期阶段，这样能够加速创新药物的上市，尽快惠及中国患者。”目前，中国是凯西在全球最有爆发力的市场之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107170601a6e83e05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107170601a6e83e05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359201612.USD","BK1191","01276","LU0359202008.SGD","LU2543165471.USD","LU0359201885.HKD","06978","LU1023057109.AUD","BK1161","BK1574"],"gpt_icon":0},{"id":"2581005089","title":"恒瑞医药11月07日主力净流出495.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2581005089","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581005089?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 16:15","pubTimestamp":1762503319,"startTime":"0","endTime":"0","summary":"11月07日, 恒瑞医药股价跌3.45%，报收69.95元，成交金额2.2亿元，换手率1.21%，振幅4.07%，量比0.73。恒瑞医药今日主力资金净流出495.6万元，上一交易日主力净流入2820.1万元。该股近5个交易日下跌6.45%，主力资金累计净流入7666.5万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入8452.3万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107161612975a15f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107161612975a15f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359202008.SGD","LU2543165471.USD","LU0359201612.USD","01276","LU0359201885.HKD","BK1191","LU1023057109.AUD"],"gpt_icon":1},{"id":"2581065074","title":"智通AH统计|11月7日","url":"https://stock-news.laohu8.com/highlight/detail?id=2581065074","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581065074?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 16:15","pubTimestamp":1762503306,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止11月7日收盘，东北电气、弘业期货、中石化油服分列AH溢价率前三位，溢价率分别为881.82%、264.44%、259.74%；宁德时代、招商银行、恒瑞医药分列AH溢价率末三位，溢价率分别为-15.21%、-0.64%、5.72%。其中东北电气、弘业期货、长飞光纤光缆的偏离值位居前三，分别为47.50%、26.95%、26.59%；另外，中远海能、中国东方航空股份、中国人寿的偏离值位居后三，分别为-13.87%、-11.53%、-11.12%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366544.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03968","LU0880133367.SGD","00753","LU1366334578.USD","BK1554","03678","00042","00670","02359","03750","BK1551","LU0072913022.USD","01033","01057","LU0648948544.HKD","LU0348805143.USD","01919","BK1133","00895","01812","06178","159982","06031","IE00BVYPNQ40.USD","00728","399300","02899","01349","LU0051755006.USD","02600","02465","02218","03143","01108","06869","06826","SG9999002828.SGD","00187","01276","02883","00300","02628","03606","01138","01988","BK1544","01375"],"gpt_icon":1},{"id":"2581005714","title":"三季度财报印证马太效应，290家医药上市企业整体减收又减利，而恒瑞医药净利57.51亿领跑","url":"https://stock-news.laohu8.com/highlight/detail?id=2581005714","media":"医药行业研究报告","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581005714?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 16:11","pubTimestamp":1762503065,"startTime":"0","endTime":"0","summary":"而恒瑞医药以57.51亿元位列以上企业的净利润榜首，同比增长24.5%。医药产业呈现马太效应，亏损企业数量增多在290家企业中，营收同比增长的企业占比44.29%，净利润同比增长的企业数量占比50.87%，反而较去年有所增加，亏损企业占比25.95%。充分说明医药行业正在形成马太效应，企业之间加剧分化。产业集中度增强，利润加速向头部企业聚集从净利润排名来看，恒瑞医药以57.51亿元强势蝉联第一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107170300a6e83baf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107170300a6e83baf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","09939"],"gpt_icon":1},{"id":"2581707451","title":"药界周刊（2025.11.1—11.7）","url":"https://stock-news.laohu8.com/highlight/detail?id=2581707451","media":"金花股份","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581707451?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 15:14","pubTimestamp":1762499677,"startTime":"0","endTime":"0","summary":"02六连板合富中国称公司股价累计涨幅已严重偏离基本面11月4日晚间，合富中国发布公告称，公司股票价格于11月3日、11月4日连续两个交易日内日收盘价格涨幅偏离值累计超过20%，根据上交所的有关规定，属于股票交易异常波动情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107155554a6e80acb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107155554a6e80acb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","BK1191","IE00BVYPNQ40.USD","LU2488822045.USD","SG9999015945.SGD","SG9999004220.SGD","IE00BYV24P56.USD","SG9999015952.SGD","00867","IE00BMCWC346.EUR","SG9999015978.USD","SG9999015986.USD","IE00BVYPNP33.GBP","BK1593","IE00BGHQDM52.EUR"],"gpt_icon":0},{"id":"2581027462","title":"【中泰策略】全A盈利改善，结构主线明确——2025年A股三季报点评","url":"https://stock-news.laohu8.com/highlight/detail?id=2581027462","media":"修炼投资的水晶球","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581027462?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 11:38","pubTimestamp":1762486727,"startTime":"0","endTime":"0","summary":"三季度销售利润率达到9.45%，较2025年二季度上升0.26%。从市值维度来看，以上证50和沪深300为代表的大盘股在2025年三季度表现相对稳健。沪深300营收同比增速1.30%，较二季度改善1.27个百分点；归母净利润同比增长5.22%，较二季度回升2.73个百分点。全A股ROE止跌回升，盈利能力边际改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107131815a6e7b387&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107131815a6e7b387&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2399975544.HKD","LU0417516738.SGD","LU0149721374.USD","LU0345780281.USD","LU0173614495.USD","01276","06099","LU0328353924.USD","LU1303224171.USD","LU0588546209.SGD","LU0181495838.USD","LU0572944931.SGD","LU0821914370.USD","LU0096374516.USD","LU1769817096.USD","BK1505","LU0469268626.HKD","LU1794554557.SGD","LU2097828631.EUR","01981","HK0000306701.USD","LU0979878070.USD","LU0266512127.USD","LU0828237940.HKD","02899","LU2097828557.USD","LU0326950275.SGD","LU1242518857.USD","LU1251922891.USD","LU1961090484.USD","HK0000320223.HKD","LU0540923850.HKD","LU0061477393.USD","LU1481107354.HKD","HK0000320264.USD","LU0211977185.USD","LU1242518931.SGD","LU1504937902.USD","LU1720050803.USD","LU1770034418.SGD","LU0327786744.USD","LU1719994722.HKD","06886","BK1594","00300","LU2097828474.EUR","SG9999002463.SGD","LU0287142896.SGD","LU0463099449.HKD","LU0886674414.USD","BK1128","LU0307460666.USD","LU0634319403.HKD","LU0370786039.SGD"],"gpt_icon":0},{"id":"2581773005","title":"拟纳入优先审评，“中国版”替尔泊肽来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2581773005","media":"CPHI制药在线","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581773005?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 11:31","pubTimestamp":1762486275,"startTime":"0","endTime":"0","summary":"近日，据中国国家药品审评中心官网最新公示，礼来苏州制药有限公司申报的替尔泊肽注射液拟纳入优先审评品种，即将迎来原研地产化。替尔泊肽是全球首款GIP/GLP-1受体激动剂，已获批用于糖尿病以及肥胖和超重患者。恒瑞医药的GLP-1/GIP双受体激动剂HRS9531注射液，在降低体重方面显示出显著效果，耐受性良好。但随着此次替尔泊肽拟纳入优先审评，恒瑞医药也将面临一定的挑战，这场“双雄对决”将是中国创新药企在全球顶尖赛道上的一次重要检验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107132534a48f3c02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107132534a48f3c02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","BK1191","01276","LU0359201885.HKD","LU1023057109.AUD","LU0359202008.SGD","LU0359201612.USD"],"gpt_icon":0},{"id":"2581050590","title":"恒瑞创新药、补体B因子抑制剂HRS-5965拟纳入优先审评程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2581050590","media":"药融圈","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581050590?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 10:50","pubTimestamp":1762483843,"startTime":"0","endTime":"0","summary":"近日，恒瑞医药子公司成都盛迪医药有限公司的1类创新药、补体B因子抑制剂HRS-5965胶囊被国家药品监督管理局药品审评中心拟纳入优先审评程序，适应症为：治疗既往未接受过补体抑制剂治疗的阵发性睡眠性血红蛋白尿症成人患者。此外，HRS-5965胶囊用于IgA肾病患者的临床研究也正在进行中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107110433a48eef69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107110433a48eef69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359201612.USD","BK1191","LU0359201885.HKD","LU0359202008.SGD","LU1023057109.AUD","06978","BK1161","BK1574","LU2543165471.USD","01276"],"gpt_icon":0},{"id":"2581609558","title":"Wellington Management Group LLP增持恒瑞医药(01276)85.56万股 每股作价72.6411港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581609558","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581609558?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 20:59","pubTimestamp":1762433984,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，11月4日，Wellington Management Group LLP增持恒瑞医药(01276)85.56万股，每股作价72.6411港元，总金额约为6215.17万港元。增持后最新持股数目约为1846.27万股，持股比例为7.15%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366260.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK0196","LU1146622755.USD","LU1997244956.HKD","LU1064130708.USD","LU1655091616.SGD","LU2097828714.EUR","LU2097828557.USD","LU1997245177.USD","LU1969619763.USD","LU0359201612.USD","LU1328615791.USD","BK0239","LU2580892862.HKD","LU1820825898.SGD","01276","LU0359201885.HKD","LU0359202008.SGD","BK0028","LU1064131003.USD","BK0183","LU2097828631.EUR","LU2488822045.USD","LU1255011170.USD","LU1023057109.AUD","LU1781817850.SGD","600276","BK1191","BK0012","LU1580142542.USD","LU2097828474.EUR","LU0405327494.USD","LU2289578879.USD","LU2148510915.USD","LU2097828805.USD","LU2580892789.USD","LU0405327148.USD","LU1997245094.SGD","LU2495084118.USD","BK0060","LU2328871848.SGD","LU2543165471.USD"],"gpt_icon":0},{"id":"2581905920","title":"八赴进博！GSK展台全新升级，变局中重构“再增长曲线”","url":"https://stock-news.laohu8.com/highlight/detail?id=2581905920","media":"MedTrend医趋势","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581905920?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 18:06","pubTimestamp":1762423601,"startTime":"0","endTime":"0","summary":"▲GSK第八届进博会展台照片眼下，中国创新药市场正经历前所未有的剧烈重构。本届进博会，GSK打破传统布局，首次全新呈现“防治结合、全生命周期”健康解决方案的布局，作为其企业战略的镜像呈现。在“预防”环节，GSK搭建的是覆盖全年龄段的健康防护体系。在“治疗”领域，GSK同样以体系化布局与多层次产品矩阵，构建“从疾病治疗到管理”的全周期方案。这意味着GSK必须在创新产品与新兴管线中找到更强的增长引擎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110618371494f31aec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110618371494f31aec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359202008.SGD","LU0359201885.HKD","LU0359201612.USD","BK1191","LU1023057109.AUD","01276","LU2543165471.USD"],"gpt_icon":0},{"id":"2581683770","title":"上海浦东三大先导产业集聚度进一步提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2581683770","media":"新华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581683770?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 17:41","pubTimestamp":1762422060,"startTime":"0","endTime":"0","summary":"新华社上海11月6日电 记者6日从第八届虹桥国际经济论坛“浦东与世界：共筑开放之路，共绘产业新图景”分论坛上获悉，浦东新区近年来持续推动科技和产业深度融合，集成电路、生物医药、人工智能三大先导产业集聚度进一步提升。目前，浦东新区已集聚生物医药领域企业超过4000家。今年以来，浦东新区已获批4款CAR-T产品、7款一类新药，创新药商务拓展交易金额达到204亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106174204a48d0c62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106174204a48d0c62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00020","BK1163","00981","BK1526","BK1607","80020","BK1610","01276","01347","BK1614"],"gpt_icon":1},{"id":"2581090548","title":"每日卖空追踪 | 恒瑞医药 11月06日卖空量成交47.44万股，卖空比例为14.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581090548","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581090548?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 16:30","pubTimestamp":1762417819,"startTime":"0","endTime":"0","summary":"恒瑞医药北京时间11月06日，涨0.21%，卖空量成交47.44万股，较上一交易日减少50.26%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110616323894f2ddf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110616323894f2ddf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359202008.SGD","01276","LU1023057109.AUD","LU0359201612.USD","LU2543165471.USD","BK1191","LU0359201885.HKD"],"gpt_icon":0},{"id":"2581061330","title":"速递 | 外国人，是如何教外企跟中国BioPharma打交道的？","url":"https://stock-news.laohu8.com/highlight/detail?id=2581061330","media":"GLP1减重宝典","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581061330?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 16:15","pubTimestamp":1762416932,"startTime":"0","endTime":"0","summary":"然而，尽管中国市场的潜力巨大，外国企业对中国生物制药公司仍抱有一定的疑虑。早期，外国企业将中国视为一个巨大的市场和生产基地，更多的是依赖外资输入和技术转移。而下面的文章，即是出自在国外咨询公司眼中，如何和中国企业打交道的报告。外国企业可能会发现，在与中国公司谈判时，单纯依靠合同和条款的严格执行往往无法解决所有问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106173148a6e5922c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106173148a6e5922c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YT58.USD","BK1515","01276","01177","IE00BZ08YS42.EUR","BK1589","BK1191","BK1521","02196","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2581905700","title":"【火热】48款新药进院在即，独家品种优势十足","url":"https://stock-news.laohu8.com/highlight/detail?id=2581905700","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581905700?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 16:13","pubTimestamp":1762416827,"startTime":"0","endTime":"0","summary":"精彩内容近日，四川大学华西第四医院发布公告，将引进48款新药以满足临床用药需求，“中化生”领域均有涉及。此前，上述2款新药已通过2025年国家基本医保目录的形式审查，若其能最终通过谈判顺利进保，将进一步拓展集团抗肿瘤药产品市场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106173140a6e59214&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106173140a6e59214&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359201885.HKD","LU1023057109.AUD","01276","LU0359201612.USD","BK1191","LU0359202008.SGD","LU2543165471.USD"],"gpt_icon":0},{"id":"2581396058","title":"恒瑞医药三季度急刹车：费用增加拖累利润，40亿海外首付款去哪了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2581396058","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581396058?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 14:40","pubTimestamp":1762411219,"startTime":"0","endTime":"0","summary":"11月4日，恒瑞医药（600276/01276）公布，截至2025年10月31日，公司通过上交所以集中竞价交易方式回购股份792万股，占总股本比例0.12%，购买的最高价70元/股，最低价62.9元/股，已支付的总金额为5.35亿元。回购背后，《财中社》注意到，恒瑞医药股价已从9月份的最高74.04元，跌至11月5日收盘的61.96元，跌幅16.32%，最新市值4112亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511063556974792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0359201612.USD","LU2543165471.USD","LU0359201885.HKD","LU1023057109.AUD","01276","BK1191","LU0359202008.SGD"],"gpt_icon":1},{"id":"2581038712","title":"1.85亿美元A轮融资！恒瑞NewCo公司Braveheart能否攻克心肌病？","url":"https://stock-news.laohu8.com/highlight/detail?id=2581038712","media":"药时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581038712?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 09:05","pubTimestamp":1762391114,"startTime":"0","endTime":"0","summary":"能让它们集体掏支票的，只有一条管线：恒瑞医药9月5日才放出的海外权益——心肌肌球蛋白抑制剂HRS-1893，如今更名BHB-1893，装进Braveheart的“唯一弹药库”。中国本土的3期试验已启动，Braveheart计划2026年直接启动全球多中心关键临床，跳过2b，用钱换时间。Braveheart能否让这款中国原创分子成为HCM领域的“最佳 in class”，2026年的全球关键临床会给出第一个答案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106094844a6e48793&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106094844a6e48793&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359202008.SGD","LU0359201885.HKD","LU0359201612.USD","LU2543165471.USD","BK1191","LU1023057109.AUD","01276"],"gpt_icon":0},{"id":"2581081286","title":"华创消费观察 | 11月观点速递：大消费三季报掘金，把握拐点","url":"https://stock-news.laohu8.com/highlight/detail?id=2581081286","media":"华创证券研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581081286?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 08:01","pubTimestamp":1762387310,"startTime":"0","endTime":"0","summary":"优先选择华润啤酒，对应明年估值不足15倍；预计三季度延续中报趋势，如果公司今年计提完白酒的减值，并购白酒的资金压力放缓之后，分红会提高。古井贡酒列为11月月度金股。上划查看更多精彩内容相关报告：《华创医药投资观点&研究专题周周谈 · 第148期：医药行业2025年三季报业绩综述》白电零售承压，但龙头仍有较强韧性。上周三大白均发布了三季报，美的、海尔三季度表现较好。一是资金面上，基金重仓家电比例Q3环比Q2大幅下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106080422a48bbc65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106080422a48bbc65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0823426308.USD","SGXZ86797644.SGD","LU0149721374.USD","LU0327786744.USD","LU0307460666.USD","LU0499858438.USD","LU0871576103.HKD","SGXZ62798434.SGD","LU0211977185.USD","BK1224","LU1770036033.HKD","LU2543165471.USD","03288","01276","02276","SG9999001069.SGD","03759","01318","LU0359201612.USD","LU0611395673.USD","LU0531971595.HKD","LU0823426480.USD","LU0164865239.USD","LU0345775950.USD","01801","LU0231483743.USD","00325","01177","LU0359201885.HKD","06690","LU0348766576.USD","06160","LU0499858602.USD","LU0593848301.USD","LU0348767384.USD","00300","LU0359202008.SGD","02145","09992","LU1023057109.AUD","IE0034224299.USD","LU0572944931.SGD","LU0588546209.SGD","LU0164880469.USD","LU1481107354.HKD","LU0345776255.USD","SG9999002950.SGD","LU0039217434.USD"],"gpt_icon":1},{"id":"2581203808","title":"新版《医疗器械生产质量管理规范》将施行；卓正医疗递表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2581203808","media":"21财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581203808?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 07:45","pubTimestamp":1762386300,"startTime":"0","endTime":"0","summary":"国家药监局发布新版《医疗器械生产质量管理规范》 将于2026年11月1日起施行据国家药监局11月4日消息，国家药监局今日发布新版《医疗器械生产质量管理规范》。新版《规范》将于2026年11月1日起施行。该产品已获得美国食品药品监督管理局同意进行临床试验的函告。资本市场卓正医疗三度递表港交所11月5日披露，卓正医疗控股有限公司向港交所主板提交上市申请书，海通国际、浦银国际为联席保荐人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110607484394f1ed20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110607484394f1ed20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","01276","LU0359201885.HKD","BK1100","BK1191","09997","LU0359202008.SGD","BK1222","BK1574","09996","BK1583","LU0359201612.USD","LU1023057109.AUD"],"gpt_icon":0},{"id":"2581223038","title":"商保创新药目录落地势必重构产业生态","url":"https://stock-news.laohu8.com/highlight/detail?id=2581223038","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581223038?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 00:04","pubTimestamp":1762358640,"startTime":"0","endTime":"0","summary":"根据安排，首版商保创新药目录拟于明年正式实施，这标志着这一备受瞩目的政策即将进入实质性落地阶段。首版商保创新药目录的诞生，是中国创新药发展的重要一环，有望开启从“支付升级”到“系统重构”的深刻变革。我们相信，随着首版商保创新药目录落地、政策与市场在动态平衡中形成合力，一个更具活力、更富韧性的中国医药创新生态将加速形成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106012454a48b2af5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106012454a48b2af5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","01276","LU0359201612.USD","LU0359201885.HKD","LU2543165471.USD","BK1574","06160","LU1023057109.AUD","BK1191","LU0359202008.SGD","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}